Process View
The progression of the venous blood vessel over time from its initial formation to the mature structure. Venous blood vessels carry blood back to the heart after the capillary bed.

In addition to gene-name show these genes:
Click on a gene's description to view its network relationships with genes known to be involved in "venous blood vessel development"
| Name | Description | Probability | Func Analog Organism | |
|---|---|---|---|---|
| TBX5 | T-box 5 | 0.963 | Human | |
| ITGA5 | integrin, alpha 5 (fibronectin receptor, alpha polypeptide) | 0.956 | ||
| NRP1 | neuropilin 1 | 0.922 | ||
| NKX2-5 | NK2 transcription factor related, locus 5 (Drosophila) | 0.920 | Mouse | |
| TGFBR2 | transforming growth factor, beta receptor II (70/80kDa) | 0.805 | ||
| KDR | kinase insert domain receptor (a type III receptor tyrosine kinase) | 0.768 | ||
| JAG1 | jagged 1 | 0.669 | ||
| NOTCH3 | notch 3 | 0.558 | ||
| PBX1 | pre-B-cell leukemia homeobox 1 | 0.539 | ||
| TGFB1 | transforming growth factor, beta 1 | 0.534 | ||
| ITGB1 | integrin, beta 1 (fibronectin receptor, beta polypeptide, antigen CD29 includes MDF2, MSK12) | 0.437 | ||
| HNF4A | hepatocyte nuclear factor 4, alpha | 0.429 | ||
| RBPJ | recombination signal binding protein for immunoglobulin kappa J region | 0.337 | ||
| GATA4 | GATA binding protein 4 | 0.268 | ||
| PRKG1 | protein kinase, cGMP-dependent, type I | 0.189 | ||
| MAPK8 | mitogen-activated protein kinase 8 | 0.143 | ||
| MAML1 | mastermind-like 1 (Drosophila) | 0.101 | ||
| NCOA7 | nuclear receptor coactivator 7 | 0.097 | ||
| ARNT | aryl hydrocarbon receptor nuclear translocator | 0.082 | ||
| XIAP | X-linked inhibitor of apoptosis | 0.072 | ||
| PGF | placental growth factor | 0.060 | ||
| MEIS2 | Meis homeobox 2 | 0.052 | ||
| NR5A2 | nuclear receptor subfamily 5, group A, member 2 | 0.052 | ||
| PDGFB | platelet-derived growth factor beta polypeptide (simian sarcoma viral (v-sis) oncogene homolog) | 0.047 | ||
| CASP7 | caspase 7, apoptosis-related cysteine peptidase | 0.045 | ||
| TGFBR1 | transforming growth factor, beta receptor 1 | 0.044 | ||
| CTBP2 | C-terminal binding protein 2 | 0.043 | ||
| JAG2 | jagged 2 | 0.042 | ||
| ARNTL | aryl hydrocarbon receptor nuclear translocator-like | 0.041 | ||
| PDGFRA | platelet-derived growth factor receptor, alpha polypeptide | 0.038 | ||
| SOX18 | SRY (sex determining region Y)-box 18 | 0.037 | ||
| NOTCH2 | notch 2 | 0.035 | ||
| CDH5 | cadherin 5, type 2 (vascular endothelium) | 0.034 | ||
| SPEN | spen homolog, transcriptional regulator (Drosophila) | 0.034 | ||
| HNF1A | HNF1 homeobox A | 0.031 | ||
| E2F2 | E2F transcription factor 2 | 0.029 | ||
| NR0B2 | nuclear receptor subfamily 0, group B, member 2 | 0.026 | ||
| CUX1 | cut-like homeobox 1 | 0.025 | ||
| EPAS1 | endothelial PAS domain protein 1 | 0.024 | ||
| TBX2 | T-box 2 | 0.024 | Human | |
| PALLD | palladin, cytoskeletal associated protein | 0.023 | ||
| GATA5 | GATA binding protein 5 | 0.022 | ||
| HOXA9 | homeobox A9 | 0.021 | ||
| BMPR1A | bone morphogenetic protein receptor, type IA | 0.021 | ||
| VEGFC | vascular endothelial growth factor C | 0.020 | ||
| SMAD7 | SMAD family member 7 | 0.020 | ||
| REL | v-rel reticuloendotheliosis viral oncogene homolog (avian) | 0.020 | ||
| FOXC1 | forkhead box C1 | 0.020 | ||
| ESAM | endothelial cell adhesion molecule | 0.019 | ||
| TBX1 | T-box 1 | 0.019 | Human | |
| THBS1 | thrombospondin 1 | 0.018 | ||
| STAB1 | stabilin 1 | 0.018 | ||
| NFKB1 | nuclear factor of kappa light polypeptide gene enhancer in B-cells 1 | 0.018 | ||
| STC1 | stanniocalcin 1 | 0.018 | ||
| MAP3K8 | mitogen-activated protein kinase kinase kinase 8 | 0.017 | ||
| FLT1 | fms-related tyrosine kinase 1 (vascular endothelial growth factor/vascular permeability factor receptor) | 0.017 | ||
| PALM2-AKAP2 | PALM2-AKAP2 readthrough | 0.017 | ||
| MSX1 | msh homeobox 1 | 0.016 | ||
| PURA | purine-rich element binding protein A | 0.016 | ||
| NPR1 | natriuretic peptide receptor A/guanylate cyclase A (atrionatriuretic peptide receptor A) | 0.016 | ||
| FLT4 | fms-related tyrosine kinase 4 | 0.016 | Zebrafish | |
| DUSP6 | dual specificity phosphatase 6 | 0.015 | ||
| FOXC2 | forkhead box C2 (MFH-1, mesenchyme forkhead 1) | 0.015 | ||
| E2F3 | E2F transcription factor 3 | 0.015 | ||
| SIX2 | SIX homeobox 2 | 0.015 | ||
| CASP9 | caspase 9, apoptosis-related cysteine peptidase | 0.015 | ||
| HOXD9 | homeobox D9 | 0.015 | ||
| DDIT4 | DNA-damage-inducible transcript 4 | 0.015 | ||
| ATXN1L | ataxin 1-like | 0.014 | ||
| FSTL1 | follistatin-like 1 | 0.014 | ||
| NKG7 | natural killer cell group 7 sequence | 0.014 | ||
| RUNX3 | runt-related transcription factor 3 | 0.014 | ||
| PRSS23 | protease, serine, 23 | 0.014 | ||
| KIR3DL2 | killer cell immunoglobulin-like receptor, three domains, long cytoplasmic tail, 2 | 0.014 | ||
| ANGPTL2 | angiopoietin-like 2 | 0.014 | ||
| BMP6 | bone morphogenetic protein 6 | 0.014 | ||
| TGFB3 | transforming growth factor, beta 3 | 0.013 | ||
| COL6A1 | collagen, type VI, alpha 1 | 0.013 | ||
| PYY | peptide YY | 0.013 | ||
| SHC2 | SHC (Src homology 2 domain containing) transforming protein 2 | 0.013 | ||
| MDM2 | Mdm2 p53 binding protein homolog (mouse) | 0.013 | ||
| LBX1 | ladybird homeobox 1 | 0.013 | ||
| VEGFA | vascular endothelial growth factor A | 0.013 | Mouse | |
| FOXF1 | forkhead box F1 | 0.013 | ||
| HS3ST3A1 | heparan sulfate (glucosamine) 3-O-sulfotransferase 3A1 | 0.013 | ||
| MYH6 | myosin, heavy chain 6, cardiac muscle, alpha | 0.012 | ||
| HOXC11 | homeobox C11 | 0.012 | ||
| NFE2L2 | nuclear factor (erythroid-derived 2)-like 2 | 0.012 | ||
| DLX4 | distal-less homeobox 4 | 0.012 | ||
| CASP3 | caspase 3, apoptosis-related cysteine peptidase | 0.012 | ||
| HOXD11 | homeobox D11 | 0.012 | ||
| FOXL1 | forkhead box L1 | 0.012 | ||
| DLL4 | delta-like 4 (Drosophila) | 0.012 | Zebrafish | |
| CXCR6 | chemokine (C-X-C motif) receptor 6 | 0.012 | ||
| MAP3K2 | mitogen-activated protein kinase kinase kinase 2 | 0.012 | ||
| FGF18 | fibroblast growth factor 18 | 0.012 | ||
| HOXB13 | homeobox B13 | 0.012 | ||
| SCARB2 | scavenger receptor class B, member 2 | 0.012 | ||
| PDGFA | platelet-derived growth factor alpha polypeptide | 0.012 | ||
| TLX1 | T-cell leukemia homeobox 1 | 0.012 | ||
| ATP2B4 | ATPase, Ca++ transporting, plasma membrane 4 | 0.012 | ||
| NR5A1 | nuclear receptor subfamily 5, group A, member 1 | 0.011 | ||
| MCAM | melanoma cell adhesion molecule | 0.011 | ||
| FOXE1 | forkhead box E1 (thyroid transcription factor 2) | 0.011 | ||
| FRK | fyn-related kinase | 0.011 | ||
| HEY1 | hairy/enhancer-of-split related with YRPW motif 1 | 0.011 | ||
| FZD10 | frizzled homolog 10 (Drosophila) | 0.011 | ||
| FOXA2 | forkhead box A2 | 0.011 | ||
| COL13A1 | collagen, type XIII, alpha 1 | 0.011 | ||
| GPR4 | G protein-coupled receptor 4 | 0.011 | ||
| RG9MTD3 | RNA (guanine-9-) methyltransferase domain containing 3 | 0.011 | ||
| EFNB2 | ephrin-B2 | 0.011 | ||
| MAF | v-maf musculoaponeurotic fibrosarcoma oncogene homolog (avian) | 0.011 | ||
| MAGED1 | melanoma antigen family D, 1 | 0.011 | ||
| SLCO2A1 | solute carrier organic anion transporter family, member 2A1 | 0.011 | ||
| HIF1A | hypoxia inducible factor 1, alpha subunit (basic helix-loop-helix transcription factor) | 0.011 | ||
| ACAN | aggrecan | 0.011 | ||
| SYDE1 | synapse defective 1, Rho GTPase, homolog 1 (C. elegans) | 0.011 | ||
| GDF11 | growth differentiation factor 11 | 0.011 | ||
| HOXB7 | homeobox B7 | 0.011 | ||
| NR2F1 | nuclear receptor subfamily 2, group F, member 1 | 0.011 | ||
| NFKBIZ | nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor, zeta | 0.011 | ||
| EGFL7 | EGF-like-domain, multiple 7 | 0.011 | ||
| HOXA11 | homeobox A11 | 0.011 | ||
| CALCR | calcitonin receptor | 0.011 | ||
| EP300 | E1A binding protein p300 | 0.010 | ||
| TIE1 | tyrosine kinase with immunoglobulin-like and EGF-like domains 1 | 0.010 | ||
| STC2 | stanniocalcin 2 | 0.010 | ||
| INHBB | inhibin, beta B | 0.010 | ||
| ADAMTS1 | ADAM metallopeptidase with thrombospondin type 1 motif, 1 | 0.010 | ||
| DYRK1A | dual-specificity tyrosine-(Y)-phosphorylation regulated kinase 1A | 0.010 | ||
| TGFBR3 | transforming growth factor, beta receptor III | 0.010 | ||
| COL5A3 | collagen, type V, alpha 3 | 0.010 | ||
| CSPG4 | chondroitin sulfate proteoglycan 4 | 0.010 | ||
| COL2A1 | collagen, type II, alpha 1 | 0.010 | ||
| CIR1 | corepressor interacting with RBPJ, 1 | 0.010 | ||
| HOXC8 | homeobox C8 | 0.010 | ||
| TBX3 | T-box 3 | 0.010 | ||
| TBX20 | T-box 20 | 0.010 | ||
| NKX3-2 | NK3 homeobox 2 | 0.010 | ||
| HOXD12 | homeobox D12 | 0.010 | ||
| FNDC3B | fibronectin type III domain containing 3B | 0.010 | ||
| ELK3 | ELK3, ETS-domain protein (SRF accessory protein 2) | 0.010 | ||
| PLXDC1 | plexin domain containing 1 | 0.010 | ||
| PHOX2B | paired-like homeobox 2b | 0.010 | ||
| LTK | leukocyte receptor tyrosine kinase | 0.010 | ||
| TBX21 | T-box 21 | 0.010 | Human | |
| CITED2 | Cbp/p300-interacting transactivator, with Glu/Asp-rich carboxy-terminal domain, 2 | 0.010 |